NecroIr2 是一种铱 (III) 复合物,是顺铂 (Cisplatin, HY-17394) 耐药肺癌细胞 (A549R) 的坏死诱导剂。NecroIr2 选择性积累在线粒体中,导致氧化应激和线粒体膜电位 (MMP) 的损失。NecroIr2 能够激活受体相互作用的丝氨酸苏氨酸激酶 3 (RIPK3) 和混合谱系激酶结构域样假激酶 (MLKL),调节CDK4表达。
生物活性 | NecroIr2 is an iridium(III) complex, serves asnecroptosisinducers inCisplatin(HY-17394)-resistant lungcancercells (A549R). NecroIr2 selectively accumulates in mitochondria, leading to oxidative stress and loss of mitochondrial membrane potential (MMP). NecroIr2 activates receptor-interactingserine-threonine kinase 3(RIPK3) andmixed lineage kinasedomain-like pseudokinase(MLKL), and regulatesCDK4expression[1]. |
IC50& Target[1] | |
体外研究 (In Vitro) | NecroIr2 (2 μM; 1-2 d) exerts subcellular distribution over 90% accumulated in mitochondria in non-labelled A549R and CFSE labelled L02 cells[1]. NecroIr2 (1.5 μM and 3 μM; 24 h) results ROS generation increasing and loss of mitochondrial membrane potential[1]. NecroIr2 (1.5 μM and 3 μM; 24 h) activates necroptosis proteins, increases the phosphorylation of RIPK1 and RIPK3[1]. NecroIr2 (0.75 μM and 1.5 μM; 24 h) induces necroptosis by arresting cell cycle at G0/G1[1]. NecroIr2 (0.375-1.5 μM; 24 h) inhibits A549R cells proliferation[1].
Western Blot Analysis[1] Cell Line: | A549R cells | Concentration: | 1.5 μM and 3 μM | Incubation Time: | 24 hours | Result: | Increased phospho-RIPK1 (p-PIPK1), total RIPK3, and phospho-RIPK3 (p-PIPK3) level. |
Cell Cycle Analysis[1] Cell Line: | A549R cells | Concentration: | 0 μM, 0.75 μM and 1.5 μM | Incubation Time: | 24 hours | Result: | Arrested cell cycle at G0/G1 phase in a dose-dependent manner. |
Cell Proliferation Assay[1] Cell Line: | A549R cells | Concentration: | 0 μM, 0.375 μM, 0.75 μM and 1.5 μM | Incubation Time: | 24 hours | Result: | Inhibits cell proliferation in a dose-dependent manner. |
|
分子量 | |
性状 | |
Formula | |
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | 4°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
溶解性数据 | In Vitro: DMSO : 50 mg/mL(53.97 mM;Need ultrasonic) 配制储备液 1 mM | 1.0794 mL | 5.3970 mL | 10.7940 mL | 5 mM | 0.2159 mL | 1.0794 mL | 2.1588 mL | 10 mM | 0.1079 mL | 0.5397 mL | 1.0794 mL |
*请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80℃, 6 months; -20℃, 1 month (sealed storage, away from moisture and light)。-80℃ 储存时,请在 6 个月内使用,-20℃ 储存时,请在 1 个月内使用。 |